EP1187934A4 - Cell-based assay for screening cox-2 inhibitors - Google Patents

Cell-based assay for screening cox-2 inhibitors

Info

Publication number
EP1187934A4
EP1187934A4 EP00941446A EP00941446A EP1187934A4 EP 1187934 A4 EP1187934 A4 EP 1187934A4 EP 00941446 A EP00941446 A EP 00941446A EP 00941446 A EP00941446 A EP 00941446A EP 1187934 A4 EP1187934 A4 EP 1187934A4
Authority
EP
European Patent Office
Prior art keywords
cox
inhibitors
screening
cell
based assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00941446A
Other languages
German (de)
French (fr)
Other versions
EP1187934A1 (en
Inventor
E Premkumar Reddy
M V Ramana Reddy
N Dhanasekaran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Publication of EP1187934A1 publication Critical patent/EP1187934A1/en
Publication of EP1187934A4 publication Critical patent/EP1187934A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP00941446A 1999-06-16 2000-06-15 Cell-based assay for screening cox-2 inhibitors Withdrawn EP1187934A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13956999P 1999-06-16 1999-06-16
US139569P 1999-06-16
PCT/US2000/016486 WO2000077245A1 (en) 1999-06-16 2000-06-15 Cell-based assay for screening cox-2 inhibitors

Publications (2)

Publication Number Publication Date
EP1187934A1 EP1187934A1 (en) 2002-03-20
EP1187934A4 true EP1187934A4 (en) 2002-07-31

Family

ID=22487303

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00941446A Withdrawn EP1187934A4 (en) 1999-06-16 2000-06-15 Cell-based assay for screening cox-2 inhibitors

Country Status (4)

Country Link
EP (1) EP1187934A4 (en)
AU (1) AU5615200A (en)
CA (1) CA2374676A1 (en)
WO (1) WO2000077245A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2690188C2 (en) * 2017-05-26 2019-05-31 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" New multitarget preparation for treating diseases in mammals

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014977A1 (en) * 1992-12-22 1994-07-07 Merck Frosst Canada Inc. HUMAN CYCLOOXYGENASE-2cDNA AND ASSAY FOR EVALUATING INHIBITION OF CYCLOOXYGENASE-2
AT402732B (en) * 1996-02-16 1997-08-25 Nycomed Austria Gmbh Use of the human megakaryocytic cell line dami for identifying and determining substances for inhibiting the enzymatic activity of the enzyme cyclooxygenase-1
AT402936B (en) * 1996-05-29 1997-09-25 Nycomed Austria Gmbh Use of a human cell line for identifying and determining substances for inhibiting the induction of the expression of the cyclooxygenase-2 gene

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014977A1 (en) * 1992-12-22 1994-07-07 Merck Frosst Canada Inc. HUMAN CYCLOOXYGENASE-2cDNA AND ASSAY FOR EVALUATING INHIBITION OF CYCLOOXYGENASE-2
AT402732B (en) * 1996-02-16 1997-08-25 Nycomed Austria Gmbh Use of the human megakaryocytic cell line dami for identifying and determining substances for inhibiting the enzymatic activity of the enzyme cyclooxygenase-1
AT402936B (en) * 1996-05-29 1997-09-25 Nycomed Austria Gmbh Use of a human cell line for identifying and determining substances for inhibiting the induction of the expression of the cyclooxygenase-2 gene

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MC DERMOTT JONATHAN M ET AL: "Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway.", ONCOGENE, vol. 18, no. 51, 2 December 1999 (1999-12-02), pages 7185 - 7189, XP001071176, ISSN: 0950-9232 *
See also references of WO0077245A1 *

Also Published As

Publication number Publication date
AU5615200A (en) 2001-01-02
WO2000077245A1 (en) 2000-12-21
WO2000077245A9 (en) 2002-06-20
EP1187934A1 (en) 2002-03-20
CA2374676A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
GB2351556B (en) Improved assay analysis
EP1165744A4 (en) Device for incubating and monitoring multiwell assays
EP0967484A4 (en) Methods for detecting or assaying virus
AU2777599A (en) Automated assaying device
AU3704200A (en) Viability assay for sporocyst-forming protozoa
IL149676A0 (en) Methods and kits for determining nucleotide variations
GB2368641B (en) Methods and compositions for assaying analytes
HK1061700A1 (en) An assay for detecting inhibitors of the enzyme myeloperokidase
EP1468107A4 (en) Methods and reagents for improved cell-based assays
GB2351555B (en) Improved assay analysis
EP1187934A4 (en) Cell-based assay for screening cox-2 inhibitors
AU5763100A (en) Non-destructive cell-based assay
GB2395266B (en) Improved assay analysis
IL138532A0 (en) Fluorescent assay for topoisomerase inhibitors
GB9910499D0 (en) Assay reagent
GB2366370B (en) Reagent for scintillation proximity assays
EP1215496A4 (en) Kit for detecting or assaying subject substance and detection or assay method
GB9905671D0 (en) Sample tester
GB9903817D0 (en) Pcr diagostic test
GB9915032D0 (en) Improved assay analysis
GB9914902D0 (en) Improved assay analysis
GB0000771D0 (en) Assay for measuring different enzyme activities simultaneously
AUPQ422299A0 (en) Sample testing
GB0009970D0 (en) Analyte detection
GB0020982D0 (en) Reagent for scintillation proximity assays

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020617

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040618

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041029